(1 - 7 von 8
)
Applying Novel Biologic Production Methods
www.genengnews.com
Supply and service companies shared their expertise at an SAFC Biosciences-sponsored seminar.
Next Generation Sequencing and its Impact on Viral Safety Testing -...
www.mynewsdesk.com
On the 4th of June 2015, a webinar was hosted by Informa and supported by BioReliance’s Global Head of Regulatory Affairs - Dr Martin Wisher regarding next...
제1회 생명공학제품 개발을 위한 국제 심포지움(11/17)newsmp.com
www.newsmp.com
15: :10 Dr. Martin Wisher (Bioreliance Co. UK) : Evaluation technology for Biosafety validation of Biologicals 16: :40 Dr. Sue N. Park (KFDA, ...
Keeping Up with Viral Safety Trends in Bioprocessing
www.genengnews.com
As promising as the technique is for giving more insight into potential viral contaminants, regulatory guidelines are slow to adopt.
Foundation Symposium 3 rd and 4 th April PACTpact.ac.at
www.pact.ac.at
— Bernd Jilma & Matt Moran Martin Wisher - Senior Director, Scientific & Regulatory Affairs, SAFC/BioReliance, United Kingdom:
Keeping Up with Viral Safety Trends in BioprocessingGenetic Engineering and Biotechnology News
www.genengnews.com
— Martin Wisher Ph.D., global head of regulatory affairs focusing on the BioReliance® portfolio of MilliporeSigma added that “in vivo studies ...
Vaccine Bioprocess Development Course — ITQB
www.itqb.unl.pt
· Facilities of the Future (Alain Pralong, GSK); Quality Control of Vaccines (Martin Wisher, Bioreliance); Polysaccharide and Conjugate Vaccine ...
sortiert nach Relevanz / Datum